Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study
Liver International · 2025
DOI: 10.1111/liv.70128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Eemeli Puhakka und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Metabolome, Fatty Liver, Alcoholic, Liver Cirrhosis, Alcoholic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jane ja Aatos Erkon Säätiö, Fonds De La Recherche Scientifique - FNRS, Alkoholitutkimussäätiö.
Abstract (Originalsprache)
Background and Aims Alcohol‐related liver disease (ALD) is a major cause of mortality and disability‐adjusted life years. It is not fully understood why a small proportion of patients develop progressive forms of ALD (e.g., fibrosis and cirrhosis). Differences in the metabolic processes could be behind the individual progression of ALD. Our aim was to examine differences in serum metabolome between patients with nonprogressive ALD and patients with an early form of progressive ALD.
Methods
The study had three study groups: progressive ALD (alcohol‐related steatohepatitis or early‐stage fibrosis, n = 50), nonprogressive ALD (simple steatosis, n = 50) and healthy controls ( n = 32). Both ALD groups took part in a voluntary alcohol rehabilitation programme. A nontargeted metabolomics analysis and targeted analysis of short‐chain fatty acids were done to the serum samples taken on the day of admission.
Results
We found 111 significantly ( p < 0.0005) altered identified metabolites between the study groups. Our main finding was that levels of glycine‐conjugated bile acids (Cohen's d = 0.90–0.91), glutamic acid ( d = 1.01), 7‐methylguanine ( d = 0.77) and several phosphatidylcholines ( d = 0.61–0.85) were elevated in the progressive ALD group in comparison to the nonprogressive ALD group. Glycine‐conjugated bile acids, glutamic acid and 7‐methylguanine also positively correlated with increased levels of aspartate aminotransferase, alanine aminotransferase, gamma‐glutamyl transferase, cell death biomarker M65 and liver stiffness.
Conclusions
Our results indicate that the enterohepatic cycle of glycine‐conjugated bile acids, as well as lipid and energy metabolism, is altered in early forms of progressive ALD. These metabolic processes could be a target for preventing the progression of ALD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Food Sciences Unit, Department of Life Technologies, University of Turku, Turku, Finland.
- Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
- Laboratory of Nutritional Psychiatry, Institute of Neuroscience, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.
- National Institute of Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
- Université de Bordeaux, NutriNeuro, Bordeaux, France.
ORCID-Profile: Eemeli Puhakka, Hany Ahmed, Retu Haikonen, Sophie Leclercq, Kati Hanhineva, Luca Maccioni, Camille Amadieu, Marko Lehtonen, Ville Männistö, Jaana Rysä, Peter Stärkel, Olli Kärkkäinen
Förderung
- Jane ja Aatos Erkon Säätiö
- Fonds De La Recherche Scientifique - FNRS
- Alkoholitutkimussäätiö
- Academy of Finland
- Research Council of Finland
Zitieren
APA
Puhakka, E., Ahmed, H., Haikonen, R., Leclercq, S., Hanhineva, K., Maccioni, L., Amadieu, C., Lehtonen, M., Männistö, V., Rysä, J., Stärkel, P., & Kärkkäinen, O. (2025). Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study. Liver International. https://doi.org/10.1111/liv.70128
Vancouver
Puhakka E, Ahmed H, Haikonen R, Leclercq S, Hanhineva K, Maccioni L, et al. Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study. Liver International. 2025. doi:10.1111/liv.70128
BibTeX
@article{Puhakka2025,
author = {Puhakka, Eemeli and Ahmed, Hany and Haikonen, Retu and Leclercq, Sophie and Hanhineva, Kati and Maccioni, Luca and Amadieu, Camille and Lehtonen, Marko and Männistö, Ville and Rysä, Jaana and Stärkel, Peter and Kärkkäinen, Olli},
title = {Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70128}
}
EUVIMED